Selected article for: "CAP mortality and validation cohort"

Author: Tristan de Jong; Victor Guryev; Yury M. Moshkin
Title: Discovery of pharmaceutically-targetable pathways and prediction of survivorship for pneumonia and sepsis patients from the view point of ensemble gene noise
  • Document date: 2020_4_11
  • ID: f5w05rc2_17
    Snippet: The CAP and sepsis patients were split into discovery (263 patients: 105 CAP and 158 sepsis patients) and validation (216 patients: 78 CAP and 138 sepsis patients) cohorts following GSE65682 annotation [8] . Within the cohorts the mortality rates were 26.2% for CAP and sepsis patients (23.8% for CAP and 27.8% for sepsis patients) in the discovery cohort, and 20.8% for CAP and sepsis patients (19.2% for CAP and 21.7% for sepsis patients) in the va.....
    Document: The CAP and sepsis patients were split into discovery (263 patients: 105 CAP and 158 sepsis patients) and validation (216 patients: 78 CAP and 138 sepsis patients) cohorts following GSE65682 annotation [8] . Within the cohorts the mortality rates were 26.2% for CAP and sepsis patients (23.8% for CAP and 27.8% for sepsis patients) in the discovery cohort, and 20.8% for CAP and sepsis patients (19.2% for CAP and 21.7% for sepsis patients) in the validation cohort.

    Search related documents:
    Co phrase search for related documents